Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD mice.
Oblak AL, Cope ZA, Quinney SK, Pandey RS, Biesdorf C, Masters AR, Onos KD, Haynes L, Keezer KJ, Meyer JA, Peters JS, Persohn SA, Bedwell AA, Eldridge K, Speedy R, Little G, Williams SP, Noarbe B, Obenaus A, Sasner M, Howell GR, Carter GW, Williams H, Lamb BT, Territo PR, Sukoff Rizzo SJ.
Oblak AL, et al. Among authors: persohn sa.
Alzheimers Dement (N Y). 2022 Jul 14;8(1):e12317. doi: 10.1002/trc2.12317. eCollection 2022.
Alzheimers Dement (N Y). 2022.
PMID: 35846156
Free PMC article.